May 25 (Reuters) - RepliCel Life Sciences Inc RP.V :
* RepliCel CEO provides company outlook
* RepliCel Life Sciences Inc - RepliCel continues to make significant progress on its nearest-term commercial asset, dermal injector (RCI-02)
* Replicel Life Sciences Inc - RepliCel has formulated a strategic plan for 2017 through 2019 focused on maturing its assets Source text for Eikon: ID:nCNWG7LH3a Further company coverage: RP.V